Monkeypox Virus Shedding Despite Tecovirimat Treatment in a Cohort in Toronto, Canada. [PDF]
J Infect DisHurst JR +12 more
europepmc +1 more source
Safety and efficacy of major antiviral and immune therapies in pregnancy for maternal viral infections: evidence synthesis of maternal and neonatal outcomes. [PDF]
Front Med (Lausanne)Sleman S +4 more
europepmc +1 more source
Mpox in a 49-year-old man with possible immune reconstitution inflammatory syndrome. [PDF]
CMAJGoto T, Maruno M, Sakamoto N.
europepmc +1 more source
Monkeypox treatment: Is tecovirimat the answer?
Journal of Infection and Public Health, 2022 Faizan Niaz +5 more
openaire +3 more sources
Monkeypox in the United States : what clinicians need to know : June 2022 [PDF]
Note: This is a technical presentation intended for healthcare professionals and contains graphic images that might not be appropriate for some audiences.
core
Information for healthcare providers on obtaining and using TPOXX (Tecovirimat) for treatment of monkeypox [PDF]
Updated August 18, 2022CDC, in partnership with FDA, has made it easier for healthcare providers to provide tecovirimat (TPOXX) treatment to patients with monkeypox under EA-IND.
core
Intervention timing and disease stage shape tecovirimat and cidofovir efficacy in male SCID mice. [PDF]
Nat CommunCao X +12 more
europepmc +1 more source
Synthesis of Antiviral Drug Tecovirimat and Its Key Maleimide Intermediates Using Organocatalytic Mumm Rearrangement at Ambient Conditions. [PDF]
Int J Mol SciSzafrański PW +6 more
europepmc +1 more source